A site where you can find recommended contractors for non-clinical testing｜effical " Non-Clinical CROs and Agencies " Inotiv, Inc.

Inotiv, Inc.

Inotiv, Inc. is a CRO that provides integrated support from drug discovery and non-clinical development to investigational new drug applications. This article surveys and summarizes the company's services and the pathological models it offers.

Features of Inotiv, Inc.'s Contract Non-clinical Trial Services

Supporting the process of new drug launches

The company offersTotal support for new drugs and medical devices from the discovery phase through non-clinical development, IND filing, and clinical developmentWe are doing so. We use our accumulated expertise to help improve efficiency and data, and reduce the cost of bringing new drugs to market.

Compliant with toxicity testing.

We provide general toxicity testing under internationally recognized regulatory guidelines to evaluate the safety of small molecules, biopharmaceutical candidates, medical devices, and non-pharmaceutical products. The scientific team has developed numerous experiences and achievements,Strong support for routine research new drug (IND) and new drug application (NDA) submissions, as well as biological license application (BLA) submissionsI will do so.

It also meets regulatory requirements such as eCTD compliance for reports and SEND compliant datasets for data, allowing for a variety of services. We can also perform general toxicity studies utilizing rodent, non-rodent, NHP (non-human primate), dog, pig, and rabbit models.

Provides DMPK analysis services

The company can meet a variety of needs in the pharmaceutical and biotechnology industries,Provides customized DMPK (pharmacokinetics and drug metabolism) analysis servicesWe do this by Based on individualized study design, rapid response, and advanced expertise, we provide data from a team of scientists with over 40 years of experience.

The company has a variety of equipment and test models, and also performs molecular and cellular level testing, including gene discovery and biomarker analysis.

3 Specialized Pre-clinical CROs for Advanced Drug Discovery

An example of Inotiv, Inc.'s pathological model

Immunodeficiency and inflammation modelsIn addition to others such as,Provides a rodent model for oncology researchIn addition, the company is also involved in In addition, the company is also involved in renal disease researchCombined model of chronic kidney disease and diabetic nephropathyand to support research on metabolic diseases,Also offers models specific to obesity and diabetesThe company is doing so.

Inotiv, Inc. Non-clinical Case Studies

No specific case studies were available on the official website.

Inotiv, Inc. Company Information

The CRO provides non-clinical and analytical drug discovery and development services to the pharmaceutical and medical device industries. The company's services focus on the development of new drugs and medical devices through the discovery and preclinical stages.

Address	2701 Kent Ave WEST LAFAYETTE, IN 47906-1350 USA
Tel	317 463-4527
Website	https://www.inotiv.com/

3 Recommended Contract Research Organizations for Non-Clinical Studies
— by Target goal and Expertise

In drug discovery, the quality and efficiency of non-clinical studies have a direct impact on clinical success rates, development costs, and overall length of time required in R&D. In recent years, there has been more demand for clinically relevant data, globally accepted reliability, and accurate early-stage screening. Thus, it is more important than ever to select the right CRO (Contract Research Organization) for strategic approach.
In this article, we highlight three CROs with proven technical capabilities, expertise, and long standing track records. These are our TOP 3 choices based on their capabilities and the specific target goals of the researchers for their non-clinical studies.

Pharmacology (Efficacy) Studies
Replicate unknown pathological models and
Discovery to clinically oriented drug evaluation

SMC Laboratories, Inc.

Reference: SMC Laboratories, Inc. official website (https://www.smccro-lab.com/jp/)

SMC Laboratories, Inc. has established a disease models using patented mouse technologies. The company has established proprietary pathological models—particularly in liver disease and fibrosis—and continues to expand their approach across a wide range of models in cancer, inflammation, and metabolic diseases.
From exploratory research to clinically oriented efficacy evaluation, SMC offers customized study designs, dosing strategies, and evaluation analysis tailored to each project. Their collaborative approachallows researchers to discuss and refine study plans together with SMC’s expert scientists.
With flexible small-scale study options and strong technical support, SMC Laboratories, Inc. is an ideal partner for start-ups, biotech ventures, and academic institutions alike.

Consult study design and disease model development
with SMC Laboratories, Inc.

Consult SMC Laboratories
Call us

Safety Studies
Comprehensive Safety Evaluation for FIH Applications

Labcorp Holdings Inc.
(Labcorp Drug Development)

Reference: Labcorp Holdings Inc. official website (https://jp.labcorp.com/)

Labcorp Holdings Inc. provides a fully integrated GLP testing system aligned with international regulatory standards, including FDA, EMA, and PMDA requirements. All studies are conducted under ICH-compliant quality assurance, making it ready for data submission.
The company has extensive expertise in long-term toxicity studies such as Segment I–III reproductive and carcinogenicity studies, as well as 2-year chronic toxicity assessments.
Labcorp Holdings Inc.’s comprehensive approach enables sponsors to efficiently outsource the entire preclinical package from toxicology, toxicokinetic (TK), and safety pharmacology study design to execution. This accelerates a path to First-in-Human (FIH) trials. For most of the global drug developers, this all-in-one service structure minimizes cost, risk, and expedite the time before advancing to clinical phase.

Consult Labcorp Holdings Inc.
Discuss GLP/ICH-compliant study design for your FIH submission.

To labcorp.
Call us

Pharmacokinetic (PK/PD) Studies
High-Precision Bioanalysis for Clinically Predictive PK/PD Evaluation

PhoenixBio Co., Ltd.

Source: PhoenixBio Co., Ltd. Official Website (https://phoenixbio.co.jp/)

PhoenixBio Co., Ltd.offers pharmacokinetic and hepatic metabolism studies using their proprietary PXB-mouse®, a humanized-liver chimeric mouse model. This platform enables the acquisition of data with high clinical correlation in ADME, drug–to-drug interaction studies, bridging the gap between preclinical and clinical stages.
With advanced LC-MS/MS-based bioanalysis, PhoenixBio Co., Ltd. provides aseamless workflow from plasma concentration measurement and metabolite identification to quantitative validation.
The company offersan integrated evaluation analysiscovering pharmacokinetics, hepatotoxicity, and safety with flexibility to accommodate complex modalities such as oligonucleotide and middle-molecule therapeutics. For compounds where hepatic metabolism is a development bottleneck—or where quantitative, reproducible exposure data are critical—PhoenixBio Co., Ltd. delivers unmatched analytical precision and consistency.

Consult Phoenix Bio for PK/PD analysis with a clinical focus

Phoenix Bio.
Call us